Cancer Peritoneal
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer (NCT03030287) | OncoMed Pharmaceuticals, Inc. | 2016-12-01 |
Track Cancer Peritoneal automatically
Every clearance here is in the API, with alerts when new ones post.